Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, N1G 2W1 Canada.
Res Vet Sci. 2013 Dec;95(3):919-23. doi: 10.1016/j.rvsc.2013.06.025. Epub 2013 Jul 30.
Toll-like receptors (TLRs) are pattern recognition receptors that mediate host responses to pathogens by promoting cellular activation and the production of cytokines. Ligands for TLRs are conserved structural motifs of pathogens termed pathogen-associated molecular patterns. In the case of TLR2, these ligands include peptidoglycan, lipomannan and lipopeptides. In mammals, it has been shown that different TLR2 ligands induce distinct cytokine responses. However, whether a similar phenomenon occurs in chickens remains to be determined. To this end, chicken splenocytes were stimulated with three different TLR2 ligands: Pam3CSK4, FSL-1 and lipomannan, and the relative gene expression of several cytokines was quantified at 2, 6 and 18h post-stimulation. The results suggest that Pam3 and FSL-1 modulate the kinetics of the pro-inflammatory cytokine response differently, as Pam3 induced a robust interleukin (IL)-1β response, while FSL-1 induced an early and prolonged up-regulation of IL-8. Furthermore, it appears that all three TLR2 ligands induce a mixed T-helper (TH) 1 and 2-like response, as characterized by the up-regulation of IFN-γ, IL-12, IL-4 and IL-13. In conclusion, we have demonstrated that different TLR2 ligands may induce different cytokine responses in chicken splenocytes. Future studies may be aimed at examining the immunomodulating effects of these ligands in vivo.
Toll 样受体 (TLRs) 是一种模式识别受体,通过促进细胞活化和细胞因子的产生,介导宿主对病原体的反应。TLRs 的配体是病原体的保守结构基序,称为病原体相关分子模式。在 TLR2 的情况下,这些配体包括肽聚糖、脂甘露聚糖和脂肽。在哺乳动物中,已经表明不同的 TLR2 配体诱导不同的细胞因子反应。然而,在鸡中是否存在类似的现象仍有待确定。为此,用三种不同的 TLR2 配体:Pam3CSK4、FSL-1 和脂甘露聚糖刺激鸡脾细胞,并在刺激后 2、6 和 18 小时定量几种细胞因子的相对基因表达。结果表明,Pam3 和 FSL-1 以不同的方式调节促炎细胞因子反应的动力学,因为 Pam3 诱导强烈的白细胞介素 (IL)-1β 反应,而 FSL-1 诱导 IL-8 的早期和持续上调。此外,似乎所有三种 TLR2 配体都诱导混合 T 辅助 (TH)1 和 2 样反应,表现为 IFN-γ、IL-12、IL-4 和 IL-13 的上调。总之,我们已经证明不同的 TLR2 配体可能在鸡脾细胞中诱导不同的细胞因子反应。未来的研究可能旨在检查这些配体在体内的免疫调节作用。